Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

A study evaluating the efficacy and safety of HAT01H in atopic dermatitis and eczema has completed Phase 1 and Phase 2 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• HAT01H

Snippet

Sponsor: Haus Bioceuticals | Conditions: Atopic Dermatitis, Eczema | Phase 1, Phase 2 | Status: COMPLETED